Cargando…

Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study

Glycomacropeptide (GMP) represents a good alternative protein source in Phenylketonuria (PKU). In a mouse model, it has been suggested to exert a prebiotic role on beneficial gut bacteria. In this study, we performed the 16S rRNA sequencing to evaluate the effect of 6 months of GMP supplementation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montanari, Chiara, Ceccarani, Camilla, Corsello, Antonio, Zuvadelli, Juri, Ottaviano, Emerenziana, Dei Cas, Michele, Banderali, Giuseppe, Zuccotti, Gianvincenzo, Borghi, Elisa, Verduci, Elvira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104775/ https://www.ncbi.nlm.nih.gov/pubmed/35565850 http://dx.doi.org/10.3390/nu14091883

Ejemplares similares

Nutrition, Microbiota and Role of Gut-Brain Axis in Subjects with Phenylketonuria (PKU): A Review
por: Verduci, Elvira, et al.
Publicado: (2020)

Proteobacteria Overgrowth and Butyrate-Producing Taxa Depletion in the Gut Microbiota of Glycogen Storage Disease Type 1 Patients
por: Ceccarani, Camilla, et al.
Publicado: (2020)

Is Gut Microbiota a Key Player in Epilepsy Onset? A Longitudinal Study in Drug-Naive Children
por: Ceccarani, Camilla, et al.
Publicado: (2021)

Nutrition and inborn errors of metabolism: challenges in Phenylketonuria
por: Verduci, Elvira, et al.
Publicado: (2014)

Phenylketonuria Diet Promotes Shifts in Firmicutes Populations
por: Bassanini, Giulia, et al.
Publicado: (2019)

The Use of Glycomacropeptide in Dietary Management of Phenylketonuria
por: Zaki, Osama K., et al.
Publicado: (2016)

Curcumin Supplementation (Meriva(®)) Modulates Inflammation, Lipid Peroxidation and Gut Microbiota Composition in Chronic Kidney Disease
por: Pivari, Francesca, et al.
Publicado: (2022)

Breastfeeding in Phenylketonuria: Changing Modalities, Changing Perspectives
por: Zuvadelli, Juri, et al.
Publicado: (2022)

Low bone mineralization in phenylketonuria may be due to undiagnosed metabolic acidosis()
por: Rovelli, Valentina, et al.
Publicado: (2023)

The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

Insights into the Role of the Microbiota and of Short-Chain Fatty Acids in Rubinstein–Taybi Syndrome
por: Di Fede, Elisabetta, et al.
Publicado: (2021)

Creatine Levels in Patients with Phenylketonuria and Mild Hyperphenylalaninemia: A Pilot Study
por: Verduci, Elvira, et al.
Publicado: (2021)

Gut dysmotility in children with neurological impairment: the nutritional management
por: Corsello, Antonio, et al.
Publicado: (2023)

Saliva detection of SARS-CoV-2 for mitigating company outbreaks: a surveillance experience, Milan, Italy, March 2021
por: Ottaviano, Emerenziana, et al.
Publicado: (2021)

Telehealth and COVID-19: Empowering Standards of Management for Patients Affected by Phenylketonuria and Hyperphenylalaninemia
por: Rovelli, Valentina, et al.
Publicado: (2021)

Exploring Drivers of Liking of Low-Phenylalanine Products in Subjects with Phenyilketonuria Using Check-All-That-Apply Method
por: Proserpio, Cristina, et al.
Publicado: (2018)

The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis
por: Pena, Maria João, et al.
Publicado: (2018)

Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective
por: Pena, Maria João, et al.
Publicado: (2021)

Effect of individual- versus collective-based nutritional-lifestyle intervention on the atherogenic index of plasma in children with obesity: a randomized trial
por: Verduci, Elvira, et al.
Publicado: (2021)

Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide Diet
por: Solverson, Patrick, et al.
Publicado: (2012)

Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
por: Pinto, A., et al.
Publicado: (2017)

Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial(1)(2)
por: Ney, Denise M, et al.
Publicado: (2016)

Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut Microbiota
por: Verduci, Elvira, et al.
Publicado: (2020)

New Insights in Cow’s Milk and Allergy: Is the Gut Microbiota the Missing Link?
por: Verduci, Elvira, et al.
Publicado: (2022)

Phenylketonuria: nutritional advances and challenges
por: Giovannini, Marcello, et al.
Publicado: (2012)

The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model
por: Ahring, Kirsten K., et al.
Publicado: (2022)

Evaluation of a New ‘Mix-In’ Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia
por: Delsoglio, Marta, et al.
Publicado: (2023)

Dysbiosis in Children With Neurological Impairment and Long-Term Enteral Nutrition
por: Panelli, Simona, et al.
Publicado: (2022)

Fat-Soluble Vitamins Deficiency in Pediatric Cholestasis: A Scoping Review
por: Degrassi, Irene, et al.
Publicado: (2023)

Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Burlina, Alberto, et al.
Publicado: (2021)

Odor–Taste–Texture Interactions as a Promising Strategy to Tackle Adolescent Overweight
por: Proserpio, Cristina, et al.
Publicado: (2021)

Dysbiosis, Host Metabolism, and Non-communicable Diseases: Trialogue in the Inborn Errors of Metabolism
por: Montanari, Chiara, et al.
Publicado: (2021)

Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?
por: Lassandro, Carlotta, et al.
Publicado: (2015)

Special Diets in Infants and Children and Impact on Gut Microbioma
por: Di Profio, Elisabetta, et al.
Publicado: (2022)

Pediatric obesity is associated with an altered gut microbiota and discordant shifts in F irmicutes populations
por: Riva, Alessandra, et al.
Publicado: (2016)

Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods
por: Stroup, Bridget M., et al.
Publicado: (2017)

Unveiling the Metabolic Effects of Glycomacropeptide
por: Pena, Maria João, et al.
Publicado: (2021)

Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria
por: Daly, Anne, et al.
Publicado: (2020)

Term Infant Formulas Influencing Gut Microbiota: An Overview
por: Fabiano, Valentina, et al.
Publicado: (2021)

What Pediatricians Should Know before Studying Gut Microbiota
por: Drago, Lorenzo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1lttv9csq5ag42arhi0r97132n